Does Timing of Cytoreductive Nephrectomy Impact Patient Survival With Metastatic Renal Cell Carcinoma in the Tyrosine Kinase Inhibitor Era? A Multi-institutional Study REPLY

被引：0
|
作者：
Derweesh, Ithaar H. [1 ]
Stroup, Sean P. [1 ]
Millard, Frederick [2 ]
机构：
[1] Univ Calif San Diego, Sch Med, Dept Surg, Div Urol, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Sch Med, Dept Internal Med, Div Med Oncol, La Jolla, CA 92093 USA
来源：
UROLOGY | 2013年 / 81卷 / 04期
关键词：
D O I：
10.1016/j.urology.2012.10.058
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：812 / 812
页数：1
相关论文
共 50 条
  • [21] Improved survival in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy in the era of targeted therapy
    Iori Sakai
    Hideaki Miyake
    Nobuyuki Hinata
    Masato Fujisawa
    International Journal of Clinical Oncology, 2014, 19 : 674 - 678
  • [22] Improved survival in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy in the era of targeted therapy
    Sakai, Iori
    Miyake, Hideaki
    Hinata, Nobuyuki
    Fujisawa, Masato
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (04) : 674 - 678
  • [23] Impact of Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy
    Song Yan
    Du Chun-Xia
    Zhang Wen
    Sun Yong-Kun
    Yang Lin
    Cui Cheng-Xu
    Chi Yihe-Bali
    Shou Jian-Zhong
    Zhou Ai-Ping
    Li Chang-Ling
    Ma Jian-Hui
    Wang Jin-Wan
    Sun Yan
    中华医学杂志英文版, 2016, 129 (05) : 530 - 535
  • [24] Impact of Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy
    Song, Yan
    Du, Chun-Xia
    Zhang, Wen
    Sun, Yong-Kun
    Yang, Lin
    Cui, Cheng-Xu
    Chi, Yihe-Bali
    Shou, Jian-Zhong
    Zhou, Ai-Ping
    Li, Chang-Ling
    Ma, Jian-Hui
    Wang, Jin-Wan
    Sun, Yan
    CHINESE MEDICAL JOURNAL, 2016, 129 (05) : 530 - 535
  • [25] Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi-institutional retrospective study (vol 27, pg 563, 2022)
    Kato, Renpei
    Naito, Sei
    Numakura, Kazuyuki
    Hatakeyama, Shingo
    Koguchi, Tomoyuki
    Kojima, Takahiro
    Kawasaki, Yoshihide
    Kandori, Shuya
    Kawamura, Sadafumi
    Arai, Yoichi
    Ito, Akihiro
    Nishiyama, Hiroyuki
    Kojima, Yoshiyuki
    Ohyama, Chikara
    Habuchi, Tomonori
    Tsuchiya, Norihiko
    Obara, Wataru
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (05) : 726 - 727
  • [26] Correction to: Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era – a multi‑institutional retrospective study
    Renpei Kato
    Sei Naito
    Kazuyuki Numakura
    Shingo Hatakeyama
    Tomoyuki Koguchi
    Takahiro Kojima
    Yoshihide Kawasaki
    Shuya Kandori
    Sadafumi Kawamura
    Yoichi Arai
    Akihiro Ito
    Hiroyuki Nishiyama
    Yoshiyuki Kojima
    Chikara Ohyama
    Tomonori Habuchi
    Norihiko Tsuchiya
    Wataru Obara
    International Journal of Clinical Oncology, 2023, 28 : 726 - 727
  • [27] Impact of Cytoreductive Nephrectomy in the Management of Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study
    Kumada, Naotaka
    Iinuma, Koji
    Kubota, Yasuaki
    Takagi, Kimiaki
    Nakano, Masahiro
    Ishida, Takashi
    Yokoi, Shigeaki
    Sugino, Fumiya
    Kawase, Makoto
    Takeuchi, Shinichi
    Kawase, Kota
    Kato, Daiki
    Takai, Manabu
    Tobisawa, Yuki
    Ito, Takayasu
    Nakane, Keita
    Koie, Takuya
    DISEASES, 2024, 12 (06)
  • [28] THE IMPACT OF CYTOREDUCTIVE NEPHRECTOMY IN METASTATIC RENAL CELL CARCINOMA - A REAL-WORLD INVESTIGATION IN THE TKI ERA
    Janisch, Florian
    Fuehner, Constantin
    Meyer, Christian P.
    Hillemacher, Tobias
    Klotzbuecher, Thomas
    Kienapfel, Christina
    Vetterlein, Malte
    Dahlem, Roland
    Shariat, Shahrokh F.
    Fisch, Margit
    Rink, Michael
    JOURNAL OF UROLOGY, 2019, 201 (04): : E344 - E344
  • [29] Histologic diversity in chromophobe renal cell carcinoma does not impact survival outcome: A comparative international multi-institutional study
    Kolar, Jiri
    Llaurado, Andrea Feu
    Ulamec, Monika
    Skenderi, Faruk
    Perez-Montiel, Delia
    Alvarado-Cabrero, Isabel
    Bulimbasic, Stela
    Sperga, Maris
    Tretiakova, Maria
    Osunkoya, Adeboye O.
    Rogala, Joanna
    Comperat, Eva
    Gal, Viliam
    Dunatov, Ana
    Pivovarcikova, Kristyna
    Michalova, Kvetoslava
    Vesela, Adriena Bartos
    Slisarenko, Maryna
    Strakova, Andrea Peterikova
    Pitra, Tomas
    Hora, Milan
    Michal, Michal
    Alaghehbandan, Reza
    Hes, Ondrej
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2022, 60
  • [30] Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy: Scientifically Relevant or Natural Selection? Reply
    Sun, Maxine
    Hanna, Nawar
    Quoc-Dien Trinh
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (11) : 1266 - 1267
12345